The country needs not only the vaccines that have demonstrated efficacy in clinical trials, but also WHO guidelines on their use.
On May 18, Deputy Chairman of the Cabinet of Ministers of Kyrgyzstan Zhyldyz Bakashova had a meeting with WHO Representative and Head of WHO Country Office in Kyrgyzstan Nazira Artykova. They noted that 420,000 vaccine doses under the COVAX programme would arrive soon in the country to combat the coronavirus. They also emphasised that the Republic needed not only the vaccines that have demonstrated efficacy in clinical trials, but also WHO guidelines on the use of vaccines, the Government of Kyrgyzstan wrote on its website.
“The re-profiling of treatment centres to admit coronavirus patients has caused the disruption of services for the prevention and treatment of non-communicable diseases, such as cardiovascular disorders, diabetes and cancer. In this regard, I would like to emphasise the importance of humanitarian aid consisting of heart monitors and medicines for non-communicable diseases,” Zhyldyz Bakashova said.
It was noted that the country needed to create mobile vaccination teams, provide technical support for e-health and build up capacity of laboratories to implement national and international quality standards and train specialists.
Nazira Artykova said the UN agency was ready to cooperate fruitfully with the Cabinet of Ministers of Kyrgyzstan in achieving the aims and objectives in the health sector, in particular, in combating the coronavirus.
